Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
about
Docking and homology modeling explain inhibition of the human vesicular glutamate transportersGlutamatergic substrates of drug addiction and alcoholismNeurotransmitter transporters and their impact on the development of psychopharmacologyMolecular targets for antiepileptic drug developmentRole of astrocytic glutamate transporter in alcohol use disorderA comprehensive review of amyotrophic lateral sclerosisStress-induced deficits in cognition and emotionality: a role of glutamateCurrent approaches to enhance glutamate transporter function and expressionSLC17: a functionally diverse family of organic anion transportersStructural insights into the substrate stereospecificity of D-threo-3-hydroxyaspartate dehydratase from Delftia sp. HT23: a useful enzyme for the synthesis of optically pure L-threo- and D-erythro-3-hydroxyaspartateThe neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?Comparison of the ontogeny of the vesicular glutamate transporter 3 (VGLUT3) with VGLUT1 and VGLUT2 in the rat retinaThe alphabet of intrinsic disorder: II. Various roles of glutamic acid in ordered and intrinsically disordered proteins.Lentiviral delivery of a vesicular glutamate transporter 1 (VGLUT1)-targeting short hairpin RNA vector into the mouse hippocampus impairs cognitionAstroglial networks and implications for therapeutic neuromodulation of epilepsy.Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats.Antibiotics that protect the brain.Glutamate as a neurotransmitter in the healthy brainThe 3-4 loop of an archaeal glutamate transporter homolog experiences ligand-induced structural changes and is essential for transport.Physical and functional interaction of NCX1 and EAAC1 transporters leading to glutamate-enhanced ATP production in brain mitochondriaAlterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndromeAbnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophreniaTwo coincidence detectors for spike timing-dependent plasticity in somatosensory cortexTranscriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEPSynapse-specific expression of functional presynaptic NMDA receptors in rat somatosensory cortexGlutamatergic targets for enhancing extinction learning in drug addictionTranscriptome analysis of food habit transition from carnivory to herbivory in a typical vertebrate herbivore, grass carp Ctenopharyngodon idella.The blood-brain barrier and glutamate.Sox9 is critical for suppression of neurogenesis but not initiation of gliogenesis in the cerebellumAdenosine Monophosphate-activated Protein Kinase Regulates Interleukin-1β Expression and Glial Glutamate Transporter Function in Rodents with Neuropathic Pain.Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.Possible roles of glutamate transporter EAAT5 in mouse cone depolarizing bipolar cell light responsesPharmacological inhibitions of glutamate transporters EAAT1 and EAAT2 compromise glutamate transport in photoreceptor to ON-bipolar cell synapses.Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.Dopaminergic neurones: much more than dopamine?Astrocyte activation in the anterior cingulate cortex and altered glutamatergic gene expression during paclitaxel-induced neuropathic pain in mice.The chemokine, macrophage inflammatory protein-2γ, reduces the expression of glutamate transporter-1 on astrocytes and increases neuronal sensitivity to glutamate excitotoxicity.Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophreniaNMDA receptors in clinical neurology: excitatory times ahead.
P2860
Q24648649-7C39B892-08E2-4033-B3C4-11FDAD979C22Q24648924-6EE0F6A6-67A7-47BD-99AB-2405BBC0DDD3Q24670273-69D6FB81-841D-46C9-8A30-324810DCA0CCQ24683346-470FB775-C4E5-4717-8E4F-12FA32E1BD6AQ26750910-1ADF25D7-D421-4E7F-9693-43AE0C739106Q26775401-428FFF86-433A-4CE2-9FDA-C5A90980E767Q26825021-018CB8DA-A313-43F1-B1E0-F60EFDB6A52AQ26996723-7F6CA04B-3E70-4F91-BD7C-C242DE8301B3Q27023513-32927A86-6D83-4B86-8E66-35EBC8663E1AQ27698066-94A53010-14E2-4467-B2E2-A877EE4AD22BQ28248515-CADBCED1-42F8-4D26-B331-E618AC63469DQ28579958-607A2D5D-46AB-44EB-A51D-AF3B208CAA3EQ30402098-300E7B2C-B650-4549-BA37-31924EED3B3FQ30422055-86C9E0BB-637C-444D-B52F-DA03857E895BQ30524466-F04FD45C-3BCA-4731-BAD9-46C56DB3D20DQ33328978-42C825AB-8762-4F28-AA06-04EF20EEBFBAQ33833157-342EF047-C117-4825-9686-16A962D084BEQ34048502-90A69C44-9FB3-4658-BCD6-680941BE2533Q34059450-7BFE50EB-615F-474F-8D33-D347D374812AQ34221922-C91E6E69-F0CA-426A-9A2E-E3C7609059E6Q34245079-1DDAC7E5-798D-4D3D-A0B0-89C9834712DAQ34406087-B0B35BFE-D6D8-4C73-AAC3-616C65B8408BQ34515044-EF82EC57-34E2-44ED-BA87-F56978C28D37Q34762404-E7CFE918-DCC1-4835-AB74-83AAA260AB4CQ34767389-76028B8D-2876-4EB1-8037-9F7F332BD9F9Q34829339-244EAFFD-9350-41A9-972A-CB7B251081C8Q35015933-B96B76CA-B522-458C-903F-E378F1E5B477Q35104343-ABD72239-6A55-406C-9133-1D42CC16D6C0Q35521424-1FBD5E14-9F2E-4374-9C2F-2822D911CD9FQ35630180-25FECE14-4109-457A-97AC-8565A26428EAQ35885971-1C530178-33D6-4FF8-BC78-AB5EE82AA886Q35984776-0E2D9D78-0E16-4E56-AE37-FD020219B725Q35989213-9ADC27DB-4F97-4291-8032-D142E013DB42Q36052481-C295433B-3830-4209-BFA3-A883F0F8D46CQ36137988-66E20B10-68CE-4CE6-BB4A-1AB4FFE73AAFQ36198137-1E62244B-2023-4F9B-B2BE-DFFD21CA56C2Q36233801-987D8894-28EC-431C-8260-6167542F6B70Q36535567-09065F04-E603-4015-87DE-890376856064Q36609289-2FED1660-A766-4131-8D9D-1ACA5F9B887CQ36660216-7D9B4A06-7361-44E5-B7CC-4DE38607347F
P2860
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@ast
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@en
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@nl
type
label
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@ast
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@en
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@nl
prefLabel
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@ast
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@en
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@nl
P3181
P1476
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
@en
P2093
Keiko Shimamoto
Yasushi Shigeri
P304
P3181
P356
10.1016/J.BRAINRESREV.2004.04.004
P407
P577
2004-07-01T00:00:00Z